Back to search
FDAFDA · Food and drugs·Recall number D-0661-2017

LATANOPROST OPHTHALMIC SOLUTION, 0.005%, 125 ug/2.5 mL, packaged in 2.5 mL bottle, Rx only, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-625-12

Published April 19, 2017 · Recall initiated: March 17, 2017

Summary

FDA records drug Class II recall D-0661-2017, published April 19, 2017 and initiated March 17, 2017. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 107,940 bottles; Lot: Lot # LAB15G52, LAB11G52, Exp 6/17; LAB18I52, Exp 8/17; LAB9L52, 11/17; LAB1A62, LAB9A62, Exp 12/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility: product was found to be empty, under-filled, or leaking.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Nationwide
Lot
Lot # LAB15G52, LAB11G52, Exp 6/17; LAB18I52, Exp 8/17; LAB9L52, 11/17; LAB1A62, LAB9A62, Exp 12/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was LATANOPROST OPHTHALMIC SOLUTION, 0.005%, 125 ug/2.5 mL, packaged in 2.5 mL bottle, Rx only, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-625-12 recalled?

Yes. FDA published recall D-0661-2017 on April 19, 2017. Reported hazard: Lack of assurance of sterility: product was found to be empty, under-filled, or leaking.

What should I do if I have this product?

Voluntary: Firm initiated · Letter